AMANDA BULL: Open Payments
NPI 1396490058 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,022 in 43 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,022
Food & beverage: $910Education: $113
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $468 |
| ABBVIE INC. | 6 | $108 |
| Aimmune Therapeutics, Inc. | 5 | $103 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $95 |
| Lilly USA, LLC | 4 | $73 |
| Ipsen Biopharmaceuticals, Inc | 3 | $65 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Ardelyx, Inc. | 1 | $23 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| EVOKE PHARMA, INC. | 1 | $17 |
Products named: TREMFYA, ZENPEP, OMVOH, IQIRVO, ENTYVIO, MAVYRET, RINVOQ, EOHILIA.
Industry payments across AR — which companies pay providers there.
